Mental Health

The FDA’s Psychopharmacologic Drugs Advisory Committee recently reviewed and voted on whether to recommend lofexidine, a non-opioid drug, for the management of opioid withdrawal.

The FDA’s Psychopharmacologic Drugs Advisory Committee recently reviewed and voted on whether to recommend lofexidine, a non-opioid drug, for the management of opioid withdrawal.

The FDA has approved a new high-capacity long-acting insulin pen for the treatment of adults with diabetes.

The FDA has approved a new high-capacity long-acting insulin pen for the treatment of adults with diabetes.

The FDA has approved a new high-capacity long-acting insulin pen for the treatment of adults with diabetes.

The US Food and Drug Administration has granted approval to the inclusion of cardiovascular safety data from the DEVOTE trial in US prescribing information for Tresiba.

The US Food and Drug Administration has granted approval to the inclusion of cardiovascular safety data from the DEVOTE trial in US prescribing information for Tresiba.

The US Food and Drug Administration has granted approval to the inclusion of cardiovascular safety data from the DEVOTE trial in US prescribing information for Tresiba.

The US Food and Drug Administration has approved a new method for administration of treatment for diabetic macular edema and diabetic retinopathy.

The US Food and Drug Administration has approved a new method for administration of treatment for diabetic macular edema and diabetic retinopathy.